RecallGuardianCanada
Drugs· Type I· Updated May 8, 2023

Emerade injection; Device failure

Critical priority
Recalled product: Emerade injection; Device failure
What you should do
  1. 1Consult your pharmacist to ensure you understand how to properly use the replacement auto-injector.
  2. 2In the event a life-threatening allergic reaction (anaphylaxis) occurs before you can obtain a replacement auto-injector, use your Emerade device and then seek emergency medical attention.
  3. 3Speak with your healthcare professional if you are concerned about your health.
  4. 4Contact Bausch Health, Canada Inc. by calling 1-800-361-4261, or emailing canada.customerservice@bauschhealth.com , if you have questions about the recall.
  5. 5Report any health product-related side effects or complaints to Health Canada.
The issue

Product quality

Affected product

Emerade Injection (0.3 mg / 0.3 mL and 0.5 mg / 0.5 mL)

Where it was sold

QCReported in the official notice — confirm there.

Issued by

Health Canada — Drugs and health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls